Home › NDC Lookup › Ingredients › Boric Acid › 52747-0155-03
V-Bella BORIC ACID 3 [hp_X]/1 Suppository, Carton of 3 — NDC 52747-0155-03 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

NDC 52747-0155-03: V-Bella BORIC ACID 3 [hp_X]/1 Suppository, Carton of 3

by U.S. PHARMACEUTICAL CORPORATION

This is a package of 3 suppositories of V-Bella BORIC ACID 3 [hp_X]/1 Suppository from U.S. PHARMACEUTICAL CORPORATION, first listed with the FDA Aug 2020 and currently FDA-listed. It is this product's only package size.

🏷️ FDA NDC (as labeled) 52747-155-03 billing pads the product segment with a zero
OTC FDA-listed Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Nov 19, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 52747-155-03 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
52747 labeler · 155 product · 03 package
Package marketed since
Aug 1, 2020
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 5274715503 2
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 52747-155-03
Product NDC 52747-155
11-digit billing NDC 52747015503
UNII R57ZHV85D4
SPL Set ID 3c3a423c-805d-4146-b16e-0138617a8dc6
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status FDA-listed
FDA listing status Listed (active directory)
Marketing start 2020-08-01
Route VAGINAL
Dosage form SUPPOSITORY
Substance BORIC ACID
Why two NDCs? The FDA registers this code as 52747-155-03 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 52747-0155-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

V-Bella Boric Acid is a vaginal suppository containing boric acid as its active ingredient. This is a homeopathic product marketed based on homeopathic tradition rather than evaluated by the FDA for effectiveness. In homeopathic practice, boric acid is traditionally used in vaginal formulations, though homeopathic products are diluted according to homeopathic principles and are not the same as conventional pharmaceutical preparations.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
52747-0155-03 You're viewing this Main listing 3 PACKET in 1 CARTON / 1 SUPPOSITORY in 1 PACKET 2020-08-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
V-Bella 3 [hp_X]this 52747-0155-03 U.S. 3 suppositories — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
Listed with the FDA since
Aug 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII WR1WPI7EW8
    A synthetic form of vitamin E used as an antioxidant. It prevents oils and fats in the medicine from breaking down and becoming rancid, helping keep the product stable during storage.
  • UNII PQ6CK8PD0R
    Ascorbic acid, also known as vitamin C, is a white crystalline powder. It serves as an antioxidant to prevent degradation of other ingredients and may also function as a preservative in the formulation.
  • UNII SA940P2U00
    A beneficial live bacterium used as a probiotic ingredient. It's included to help maintain or support healthy gut bacteria in the digestive system.
  • UNII Q66E0D2443
    A live microorganism strain used as a probiotic ingredient. It's included to support beneficial bacteria in the digestive system and improve product stability.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII 8ZQ0AYU1TT
    Pullulan is a natural polysaccharide, a type of carbohydrate made from yeast. It acts as a binder and film-former to hold tablet ingredients together and create protective coatings on capsules.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesMaltodextrin, Antioxidants-Vitamin E (DL-Alpha-Tocopheryl Acetate) &  Vitamin C (Ascorbic Acid), Lactobacillus casei (KE-99), Lactobacillus gasseri and Capsule Ingredient (Pullulan). Adverse reactions and side effects The adverse effects are considered mild and may include watery discharge, erythema, or slight burning sensation. You should contact your healthcare provider for medical advice about adverse events or report a serious adverse event, by contacting BeBe & Bella, LLC. at the address listed below. Distributed by: BeBe & Bella, LLC 2443 Park Central Blvd. Decatur, GA 30035, USA

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerU.S. PHARMACEUTICAL CORPORATION
Labeler code52747
First marketedAug 2020
Product typeHuman Otc Drug
Portfolio7 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 39 words ▾

Uses treats and relieves symptoms of vaginal and urinary infections. rebalances vaginal pH and restores normal vaginal health. helps relieve symptoms of external and internal vaginal burning, itching, irritation and dryness. helps reduce vaginal odor due to vaginal infections.

⏱️ Dosage and Administration 77 words ▾

Directions before using this product, read all consumer information provided on carton and insert, Adults and children 12 years of age and over: place vaginal capsule suppository in applicator and gently insert into the vagina. for acute infection, use one (1) capsule suppository a day for three (3) days for chronic infection, use an additional package of three (3) vaginal capsule suppositories throw applicator away after each use Children under 12 years of age: ask a doctor

⚠️ Warnings 5 words ▾

Warnings For vaginal use only

📦 How Supplied / Storage and Handling 104 words ▾

How supplied, storage and handling V-Bella ™ is supplied in a clear natural plantcap capsule in three (3) individual foil packets of one (1) capsule each, NDC # 52747-0155-03 with three (3) disposable vaginal applicators in each carton. Avoid sunlight and store unopened pouches at 15˚ to 30˚ C (59˚ to 86˚ F) Other information V-Bella ™ is not a contraceptive and should not be used to prevent pregnancy or to prevent or treat sexually transmitted diseases (STDs). do not use if suppository pouch seal is compromised do not use if seal over applicator has been punctured do not purchase if carton is open

📦 Storage and Handling 14 words ▾

Other information Store between 15-30C (59-86F) Avoid freezing and excessive heat above 40C (104F)

🧪 Active Ingredient 29 words ▾

Active Ingredient Boricum Acidum 3X* HPUS** *X is a homeopathic dilution. **The letters HPUS indicates that this ingredient is officially monographed in the Homeopathic Pharmacopoeia of the United States.

🧪 Inactive Ingredients 86 words ▾

Inactive ingredients Maltodextrin, Antioxidants-Vitamin E (DL-Alpha-Tocopheryl Acetate) & Vitamin C (Ascorbic Acid), Lactobacillus casei (KE-99), Lactobacillus gasseri and Capsule Ingredient (Pullulan). Adverse reactions and side effects The adverse effects are considered mild and may include watery discharge, erythema, or slight burning sensation. You should contact your healthcare provider for medical advice about adverse events or report a serious adverse event, by contacting BeBe & Bella, LLC. at the address listed below.

Distributed by : BeBe & Bella, LLC 2443 Park Central Blvd. Decatur, GA 30035, USA

🎯 Purpose 11 words ▾

Purpose Restores vaginal pH and relieves vaginal itching, burning and irritation.

📄 Do Not Use 19 words ▾

Do not use Do not use if you have never had a vaginal yeast infection diagnosed by a doctor.

📄 When Using This Product 162 words ▾

Ask a doctor before use if you have vaginal itching and discomfort for the first time lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a more serious condition. vaginal yeast infection often (such as once a month or 3 in 6 months). You could be pregnant or a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system. been exposed to human immunodeficiency virus (HIV) that causes AIDS.

Ask a doctor or pharmacist before use if you are taking prescription blood thinning medicine warfarin, because bleeding or bruising may occur. When using this product do not use tampons, douches, spermicides or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexual transmitted disease (STDs). do not have vaginal intercourse mild increase in vaginal burning, itching or irritation may occur if you do not get complete relief ask a doctor before using another product

📄 Stop Use and Ask a Doctor If 48 words ▾

Stop use and ask a doctor if symptoms do not get better in 3 days symptoms last more than 7 days you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. If pregnant or breast-feeding , ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1- 800-222-1222) right away.

📄 Package Label / Principal Display Panel 7 words ▾

Package Label - Principal Display Panel Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for V-Bella (this brand).

Top reported reactions

Arthralgia114
Pain In Extremity113
Joint Swelling112
Infection110
Musculoskeletal Stiffness110
Hepatotoxicity109
Condition Aggravated108

Age at onset

Child3
Adult57
Elderly12

Reporter sex

345 reports
Male · 18%
Female · 82%
Unknown · 0%

Serious outcomes

Hospitalization179
Death42
Life-threatening32
Disabling14
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 77 10
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

V-Bella BORIC ACID 3 [hp_X]/1 SUPPOSITORY is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by U.S. PHARMACEUTICAL CORPORATION. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
U.S. PHARMACEUTICAL CORPORATION is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.